Yuhan Corporation

Heui Ii Kang

Dong-Hoon Kim

Moo Young Song

Jae Sun Lee

Young-Ae Yoon

Jae-Gyu Kim

Myung-Hun Cha

Hyouk-Woo Lee

Suk-Won Yoon

In Young Ko

Byung-Nak Ahn

Chan-Sun Park

Tae Hyoung Yoo

Chang Seok Kim

Kang In Na

Sang Koo Park

Sun-Young Jang

Seok-Hee Han

The present invention provides novel pyrrolo[2,3-c]pyridine derivatives or pharmaceutically acceptable salts thereof, processes for the preparation thereof, and compositions comprising the same. The pyrrolo[2,3-c]pyridine derivatives or pharmaceutically acceptable salts thereof of the present invention have excellent proton pump inhibition effects and possess the ability to attain a reversible proton pump inhibitory effect.

Pyrrolo[2,3-C]pyridine derivatives and processes for the preparation thereof

An antibody variable region of a monoclonal antibody specifically binding to human tumor necrosis factor-&#x3b1; contains at least one of a heavy chain variable region and a light chain variable region having specific complementarity determining regions therein. A nucleic acid molecule encoding the same, a recombinant vector containing the nucleic acid molecule, and a cell transformed with the recombinant vector are also provided.

Antibody variable region of a monoclonal antibody against human tumor necrosis factor alpha and a gene encoding the same

Growing community of inventors

Seoul, South Korea

Heui Ii Kang